143 related articles for article (PubMed ID: 38234071)
1. Triggers, clinical manifestations and assessment of paediatric fixed drug eruptions: A systematic review of the literature.
Mathieu A; de Grandmont M; Fernandes CL; Kechichian E
Contact Dermatitis; 2024 Apr; 90(4):343-349. PubMed ID: 38234071
[TBL] [Abstract][Full Text] [Related]
2. [Fixed drug eruption to clarithromycin: The importance of challenge tests in diagnosis].
Huynh VA; Lungoci E; Villani A; Ben Said B; Hacard F; Nicolas JF; Bérard F
Ann Dermatol Venereol; 2016 Dec; 143(12):852-855. PubMed ID: 27080820
[TBL] [Abstract][Full Text] [Related]
3. Fixed Drug Eruptions: An Update, Emphasizing the Potentially Lethal Generalized Bullous Fixed Drug Eruption.
Patel S; John AM; Handler MZ; Schwartz RA
Am J Clin Dermatol; 2020 Jun; 21(3):393-399. PubMed ID: 32002848
[TBL] [Abstract][Full Text] [Related]
4. Probable etoricoxib-induced fixed drug eruption involving the oral mucosa: A case report.
Perks A; Bates TJ; Velangi S; Brown RM; Poveda-Gallego A
Oral Surg Oral Med Oral Pathol Oral Radiol; 2021 Apr; 131(4):e100-e107. PubMed ID: 33468439
[TBL] [Abstract][Full Text] [Related]
5. A three-year-analysis of fixed drug eruptions in hospital settings in France.
Brahimi N; Routier E; Raison-Peyron N; Tronquoy AF; Pouget-Jasson C; Amarger S; Machet L; Amsler E; Claeys A; Sassolas B; Leroy D; Grange A; Dupuy A; Cordel N; Bonnetblanc JM; Milpied B; Doutre MS; Guinnepain MT; Barbaud A; Chosidow O; Roujeau JC; Lebrun-Vignes B; Descamps V
Eur J Dermatol; 2010; 20(4):461-4. PubMed ID: 20507840
[TBL] [Abstract][Full Text] [Related]
6. Clinical features, culprit drugs, and allergology workup in 41 cases of fixed drug eruption.
Ben Fadhel N; Chaabane A; Ammar H; Ben Romdhane H; Soua Y; Chadli Z; Zili J; Boughattas NA; Ben Fredj N; Aouam K
Contact Dermatitis; 2019 Nov; 81(5):336-340. PubMed ID: 31291002
[TBL] [Abstract][Full Text] [Related]
7. Piroxicam-induced fixed drug eruption: Cross-reactivity with meloxicam.
Ben Romdhane H; Ammar H; Ben Fadhel N; Chadli Z; Ben Fredj N; Boughattas NA; Chaabane A; Aouam K
Contact Dermatitis; 2019 Jul; 81(1):24-26. PubMed ID: 30663057
[TBL] [Abstract][Full Text] [Related]
8. Provocation tests in a chlormezanone-induced fixed drug eruption.
Lee AY; Lee YS
DICP; 1991 Jun; 25(6):604-5. PubMed ID: 1831577
[TBL] [Abstract][Full Text] [Related]
9. An update of fixed drug eruptions in Singapore.
Heng YK; Yew YW; Lim DS; Lim YL
J Eur Acad Dermatol Venereol; 2015 Aug; 29(8):1539-44. PubMed ID: 25491106
[TBL] [Abstract][Full Text] [Related]
10. Fixed drug eruption following metronidazole therapy and the use of topical provocation testing in diagnosis.
Short KA; Fuller LC; Salisbury JR
Clin Exp Dermatol; 2002 Sep; 27(6):464-6. PubMed ID: 12372086
[TBL] [Abstract][Full Text] [Related]
11. Oral mucosal fixed drug eruption: characteristics and differential diagnosis.
Özkaya E
J Am Acad Dermatol; 2013 Aug; 69(2):e51-8. PubMed ID: 23044075
[TBL] [Abstract][Full Text] [Related]
12. Etoricoxib-induced fixed drug eruption: Report of seven cases.
Martínez Antón MD; Galán Gimeno C; Sánchez de Vicente J; Jáuregui Presa I; Gamboa Setién PM
Contact Dermatitis; 2021 Mar; 84(3):192-195. PubMed ID: 32666601
[TBL] [Abstract][Full Text] [Related]
13. Patch testing for evaluating drug reactions due to systemic antibiotics.
Cham PM; Warshaw EM
Dermatitis; 2007 Jun; 18(2):63-77. PubMed ID: 17498411
[TBL] [Abstract][Full Text] [Related]
14. A Review of Fixed Drug Eruption with a Special Focus on Generalized Bullous Fixed Drug Eruption.
Anderson HJ; Lee JB
Medicina (Kaunas); 2021 Sep; 57(9):. PubMed ID: 34577848
[TBL] [Abstract][Full Text] [Related]
15. Bullous fixed drug eruption: A potential diagnostic pitfall: a study of 18 cases.
Zaouak A; Ben Salem F; Ben Jannet S; Hammami H; Fenniche S
Therapie; 2019 Oct; 74(5):527-530. PubMed ID: 31006486
[TBL] [Abstract][Full Text] [Related]
16. Fixed drug eruption: state of the art.
Ozkaya E
J Dtsch Dermatol Ges; 2008 Mar; 6(3):181-8. PubMed ID: 18076661
[TBL] [Abstract][Full Text] [Related]
17. Vesicular Contact Reaction May Progress into Erythema Multiforme.
Czarnecka-Operacz M; Jenerowicz D; Szulczyńska-Gabor J; Teresiak-Mikołajczak E; Szyfter-Harris J; Bowszyc-Dmochowska M
Acta Dermatovenerol Croat; 2016 Dec; 24(4):307-309. PubMed ID: 28128086
[TBL] [Abstract][Full Text] [Related]
18. Topical provocation in fixed drug eruption due to metamizol and naproxen.
Ozkaya-Bayazit E
Clin Exp Dermatol; 2004 Jul; 29(4):419-22. PubMed ID: 15245546
[TBL] [Abstract][Full Text] [Related]
19. Clindamycin-induced Maculopapular Exanthema with Preferential Involvement of Striae Distensae: A Koebner phenomenon?
Monteagudo B; Cabanillas M; Iriarte P; Ramírez-Santos A; León-Muinos E; González-Vilas D; Suárez-Amor Ó
Acta Dermatovenerol Croat; 2018 Apr; 26(1):61-63. PubMed ID: 29782303
[TBL] [Abstract][Full Text] [Related]
20. Topical provocation of fixed drug eruption. A study of 30 patients.
Alanko K
Contact Dermatitis; 1994 Jul; 31(1):25-7. PubMed ID: 7924289
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
